Hermetica Superfood Encyclopedia
The Short Answer
Trametes trogii produces beta-glucan polysaccharides and laccase enzymes that modulate immune cell activity and exhibit antioxidant and putative antitumor effects via immunomodulatory and oxidative-stress-related pathways. Preclinical laboratory studies have identified antioxidant activity and high laccase production in cultured strains, though DPPH radical-scavenging capacity remained below 50% relative to ascorbic acid controls, indicating moderate antioxidant potency.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordTrametes trogii benefits
Trog's Trametes — botanical close-up
Health Benefits
**Immunomodulation via Polysaccharides**
Beta-glucan polysaccharides isolated from Trametes trogii mycelium and fruiting bodies interact with pattern-recognition receptors on macrophages and dendritic cells, potentially upregulating cytokine production and enhancing innate immune surveillance.
**Antioxidant Activity**: Cultured strains of T
trogii demonstrate free-radical scavenging capacity in DPPH assays, attributed to phenolic compounds and antioxidant enzymes produced during mycelial growth, though activity is moderate compared to reference antioxidants.
**Putative Antitumor Properties**: Consistent with other Trametes species, T
trogii polysaccharides are hypothesized to exert antitumor effects by activating natural killer (NK) cells and cytotoxic T lymphocytes, though direct evidence for this species remains at the preclinical stage.
**Laccase Enzyme Production**: T
trogii is a prolific producer of laccase (up to 0.55 U/mL under optimal culture conditions), a multicopper oxidase enzyme with potential biotechnological and detoxification applications, and which may contribute to the mushroom's bioactive phenolic compound profile.
**Anti-inflammatory Potential**
Polysaccharide fractions from related Trametes species modulate NF-κB signaling pathways to reduce pro-inflammatory cytokine expression; T. trogii is hypothesized to share this mechanism based on structural similarities in its glucan fractions.
**Manganese Peroxidase Activity**: T
trogii also produces manganese peroxidase, an enzyme capable of oxidizing a range of phenolic substrates, which may contribute indirectly to its antioxidant and bioactive compound generation profile.
Origin & History
Natural habitat
Trametes trogii is a white-rot basidiomycete fungus distributed across temperate and subtropical regions of Europe, Asia, and North Africa, typically colonizing dead or dying hardwood trees including poplar, willow, and elm. It produces bracket-shaped fruiting bodies on decaying wood and thrives in humid woodland environments with moderate temperatures. Like other Trametes species, it can be cultivated on lignocellulosic substrates such as sawdust and straw under controlled laboratory and commercial conditions.
“Trametes trogii was first formally described by the British mycologist Miles Joseph Berkeley in the 19th century, and the species name honors the Swiss entomologist Johann Jakob Trog, reflecting its early documentation in European natural history rather than a primary tradition of medicinal use. Unlike T. versicolor (Yun Zhi), which has centuries of documented use in Chinese and Japanese traditional medicine for immune support and cancer adjunct therapy, T. trogii does not appear prominently in historical ethnomycological pharmacopoeias from any major traditional medicine system. In regions where it naturally occurs, including parts of the Mediterranean basin and Central Asia, bracket fungi of the Trametes genus were occasionally used in folk medicine for their perceived tonic and wound-healing properties, though species-level identification in historical accounts is rarely certain. Contemporary interest in T. trogii has emerged primarily from its biotechnological potential as a laccase-producing organism for industrial applications such as textile dye decolorization, pulp bleaching, and biosensor development rather than from an established medical tradition.”Traditional Medicine
Scientific Research
Published research on Trametes trogii is sparse and predominantly limited to in vitro and culture-based studies focusing on enzymatic production and antioxidant screening rather than therapeutic efficacy. Studies have confirmed that different T. trogii strains vary significantly in antioxidant capacity depending on culture medium, with malt extract broth yielding higher activity than potato dextrose or other substrates, though all strains tested fell below 50% DPPH radical inhibition relative to ascorbic acid controls. No peer-reviewed clinical trials in human subjects have been published specifically for T. trogii, and the antitumor and immunomodulatory claims attributed to this species are largely extrapolated from more extensively studied congeners such as T. versicolor (turkey tail), which has undergone Phase I and Phase II oncology trials. The overall evidence base for T. trogii as a medicinal ingredient remains at the preliminary preclinical stage, and robust dose-response, pharmacokinetic, or safety data in humans are absent from the published literature.
Preparation & Dosage
Traditional preparation
**Dried Fruiting Body Powder**
1–3 g/day of dried powder
No clinically validated dose has been established for T. trogii specifically; doses used for related Trametes species typically range from .
**Hot Water Extract (Polysaccharide-Rich)**
Aqueous decoctions or extracts designed to maximize beta-glucan extraction are the traditional and most pharmacologically relevant preparation; standardized to 20–40% beta-glucan content by analogy with T. versicolor extracts.
**Mycelial Biomass**
Laboratory and biotechnological studies use mycelial cultures grown in liquid media (e.g., malt extract broth) for enzyme and polysaccharide extraction; not a standardized consumer product form.
**Alcohol Extract (Tincture)**
Ethanolic extraction captures phenolic antioxidants and small-molecule bioactives; typical tincture ratios of 1:5 (w/v) are used in analogous medicinal mushroom preparations.
**Timing**
Medicinal mushroom supplements are generally taken with meals to improve tolerability; no T. trogii-specific timing data exist.
**Standardization Note**
No pharmacopoeial or industry standard for T. trogii extract potency has been established; consumers should verify beta-glucan content on product labels if purchasing related Trametes products.
Nutritional Profile
Like other Trametes species, T. trogii fruiting bodies and mycelium contain beta-glucan polysaccharides as the primary bioactive macromolecules, estimated at 15–40% of dry weight depending on strain and substrate, though species-specific quantification data are limited. The fruiting body provides modest amounts of dietary protein (approximately 10–20% of dry weight), with a complement of essential amino acids including leucine, valine, and lysine. Trace minerals including potassium, phosphorus, magnesium, and selenium are present in mycelium, consistent with the mineral profile of wood-decaying basidiomycetes. Phenolic compounds including flavonoids and hydroxycinnamic acid derivatives contribute to the measured antioxidant activity, while ergosterol (a precursor to vitamin D2 upon UV exposure) is present in the fungal cell membrane. Bioavailability of beta-glucans from intact fruiting body material is limited by the chitin cell wall matrix, and hot water extraction substantially improves polysaccharide accessibility compared to raw powder.
How It Works
Mechanism of Action
The primary proposed mechanism of T. trogii involves beta-1,3/1,6-glucan polysaccharides binding to Dectin-1 and other beta-glucan receptors on macrophages and monocytes, triggering downstream MAPK and NF-κB signaling cascades that amplify immune cell activation and cytokine release. Laccase enzymes produced by T. trogii catalyze the one-electron oxidation of phenolic substrates and aromatic amines, generating reactive quinone intermediates and contributing to the organism's oxidative-stress-modulating capacity. Additionally, phenolic metabolites present in mycelial extracts may inhibit lipid peroxidation and scavenge superoxide and hydroxyl radicals through hydrogen atom transfer mechanisms. The manganese peroxidase co-produced alongside laccase may further oxidize lignin-derived phenolics into bioactive low-molecular-weight compounds that contribute to the overall antioxidant activity of crude extracts.
Clinical Evidence
There are currently no published randomized controlled trials or formal clinical trials that specifically evaluate the therapeutic effects of Trametes trogii in human subjects. The available evidence consists of in vitro fermentation studies and antioxidant assays conducted in laboratory settings, with findings that confirm enzymatic activity and moderate free-radical scavenging but do not establish clinically meaningful effect sizes for any human health outcome. Comparative data from the related species T. versicolor suggest that Trametes polysaccharides can support immune function during chemotherapy, but these findings cannot be directly attributed to T. trogii without species-specific trials. Confidence in clinical benefit for T. trogii specifically remains very low, and any health claims for this species should be considered provisional pending formal investigation.
Safety & Interactions
No formal safety studies, toxicology reports, or adverse event data have been published specifically for Trametes trogii in human subjects, making it impossible to establish a confirmed safety profile or maximum tolerable dose at this time. By analogy with the closely related T. versicolor, which has demonstrated a favorable safety profile in oncology trials at doses up to 9 g/day of standardized extract, T. trogii is not expected to be acutely toxic at typical mushroom supplement doses, but this assumption is unvalidated. Potential drug interactions have not been studied for T. trogii; however, immunomodulatory polysaccharides from Trametes species may theoretically augment or interfere with immunosuppressive medications (e.g., cyclosporine, tacrolimus, corticosteroids) and warrant caution in transplant recipients or patients on immunosuppressive therapy. Guidance for use during pregnancy and lactation cannot be provided due to a complete absence of reproductive safety data, and avoidance is prudent; individuals with mushroom allergies or mold sensitivities should also exercise caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Trametes trogii Berk.Trog's TrametesCoriolus trogiiPolyporus trogiiT. trogii
Frequently Asked Questions
What is Trametes trogii used for?
Trametes trogii is primarily studied for its beta-glucan polysaccharides, which are hypothesized to support immune function and exhibit antitumor properties similar to the related species T. versicolor (turkey tail). It also produces high levels of the enzyme laccase, making it valuable in biotechnological applications such as industrial dye decolorization. Its direct medicinal use in humans has not been validated by clinical trials.
Is Trametes trogii the same as turkey tail mushroom?
No, Trametes trogii is a distinct species from Trametes versicolor (turkey tail), although both belong to the same genus and share structural similarities in their polysaccharide profiles and laccase-producing ability. T. versicolor is far more extensively studied, with published clinical trials in cancer patients, while T. trogii lacks equivalent human research. The two species differ in morphology, geographic prevalence, and the specific composition of their bioactive compounds.
What antioxidant activity does Trametes trogii have?
Laboratory studies using DPPH radical-scavenging assays found that T. trogii strains exhibit antioxidant activity, but all tested strains demonstrated less than 50% inhibition relative to ascorbic acid as a positive control. Antioxidant potency varied significantly by culture medium, with malt extract broth producing higher activity than other substrates. The antioxidant compounds are attributed to phenolic metabolites and enzymatic activity, though specific compound identification and concentrations have not been fully characterized for this species.
What enzymes does Trametes trogii produce?
Trametes trogii is recognized as a potent producer of laccase, a multicopper oxidase enzyme, with activity levels reported up to 0.55 U/mL under optimized culture conditions. It also produces manganese peroxidase, though at lower levels than laccase. These ligninolytic enzymes are of significant biotechnological interest for applications in bioremediation, paper pulp processing, and green chemistry, and may also contribute to the generation of bioactive phenolic compounds in fungal extracts.
Is Trametes trogii safe to take as a supplement?
The safety of Trametes trogii as a human supplement has not been formally evaluated in published toxicology studies or clinical trials. No adverse event data are available for this specific species, and no maximum safe dose has been established. Based on analogy with the closely related T. versicolor, which showed a favorable safety profile in oncology trials, T. trogii is not expected to be acutely harmful, but individuals taking immunosuppressive drugs, those who are pregnant or breastfeeding, or those with mushroom allergies should avoid use until species-specific safety data are available.
What is the difference between Trametes trogii mycelium and fruiting body supplements?
Both mycelium and fruiting bodies of Trametes trogii contain bioactive beta-glucan polysaccharides, but fruiting bodies typically have higher concentrations of these immune-supporting compounds. Mycelium-based supplements may be easier to cultivate and standardize, while fruiting body extracts are often considered more potent for immunomodulation studies. The choice between the two depends on standardization levels and extraction methods used by the manufacturer.
How do Trametes trogii polysaccharides work in the immune system?
Trametes trogii's beta-glucan polysaccharides bind to pattern-recognition receptors on immune cells like macrophages and dendritic cells, triggering the release of cytokines that enhance innate immune surveillance. This interaction helps activate and coordinate the body's natural defense mechanisms without overstimulation. The mechanism is similar to other medicinal mushrooms but is specific to T. trogii's polysaccharide composition.
Does Trametes trogii have better antioxidant potential than other medicinal mushrooms?
Trametes trogii demonstrates free-radical scavenging capacity in cultured studies, though direct comparative research with other medicinal mushrooms is limited in published literature. Its antioxidant activity appears complementary to its immunomodulatory effects through polysaccharides, creating a dual mechanism of action. More clinical comparisons are needed to definitively rank its antioxidant potency against species like reishi or maitake.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w trametes-trogii-trametes-trogii-berk curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
